Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

These findings suggest that many miRNAs expressions are altered in BC, whose expression profiling may provide a useful clue for the pathophysiological research. Circulating miR-92a has potential use as novel breast cancer biomarker, which is comparable to miR-21.